Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of government agencies regarding cost-effectiveness claims: FDA perspective.
作者信息
Temple R
机构信息
Center for Drugs Evaluation and Research, US Food and Drug Administration, Rockville, MD 20857, USA.
出版信息
Am Heart J. 1999 May;137(5):S75-7. doi: 10.1016/s0002-8703(99)70434-5.
Abstract
摘要
Zotero 插件